Merit Medical Systems, Inc.

61
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5898891040
USD
69.17
-0.78 (-1.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Merit Medical Systems, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
170.00
149.00
112.00
82.00
53.00
-13.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-23.00
-36.00
-70.00
-71.00
-17.00
34.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
297.00
220.00
145.00
114.00
147.00
165.00
Cash Flow from Investing Activities
-247.00
-368.00
-175.00
-57.00
-37.00
-58.00
Cash Flow from Financing Activities
15.00
-60.00
559.00
-60.00
-98.00
-95.00
Net Cash Inflow / Outflow
69.00
-210.00
528.00
-7.00
10.00
12.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
-2.00
0.00
-3.00
0.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Merit Medical Systems, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
170.937
147.506
23.00
15.88%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-23.344
28.044
-51.00
-183.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
297.371
282.821
15.00
5.14%
Cash Flow from Investing Activities
-247.386
-135.144
-112.00
-83.05%
Cash Flow from Financing Activities
15.999
-96.16
111.00
116.64%
Net Cash Inflow / Outflow
69.782
67.591
2.00
3.24%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.798
16.074
-13.00
-76.37%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 34.68% vs 52.12% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
297.37
220.80
34.68%